RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $126,000 | -46.6% | 22,802 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $236,000 | -47.4% | 24,408 | -2.9% | 0.00% | -50.0% |
Q3 2021 | $449,000 | -27.2% | 25,138 | -0.5% | 0.00% | 0.0% |
Q2 2021 | $617,000 | +11.4% | 25,263 | +20.9% | 0.00% | 0.0% |
Q1 2021 | $554,000 | +250.6% | 20,889 | +0.3% | 0.00% | +100.0% |
Q4 2020 | $158,000 | +47.7% | 20,834 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $107,000 | -18.3% | 21,433 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $131,000 | +42.4% | 21,919 | +6.0% | 0.00% | 0.0% |
Q1 2020 | $92,000 | -55.8% | 20,684 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $208,000 | +20.2% | 21,880 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $173,000 | -50.4% | 22,065 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $349,000 | -11.2% | 22,218 | +2.2% | 0.00% | 0.0% |
Q1 2019 | $393,000 | +204.7% | 21,736 | +171.3% | 0.00% | 0.0% |
Q4 2018 | $129,000 | -33.5% | 8,011 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $194,000 | – | 8,072 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
Artal Group S.A. | 2,042,666 | $357 | 0.02% |
Virtu Financial LLC | 68,825 | $12 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
Citadel Advisors | 600 | $103 | 0.00% |
Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |